MUMBAI, INDIA – November 26, 2025 – The allotment for Sudeep Pharma's Rs 895 crore initial public offering wrapped up Wednesday, with shares oversubscribed 93.71 times amid strong investor interest.
Registrar MUFG Intime India processed bids for 99 crore shares against 1.05 crore on offer. Retail grabbed 45.2 times quota, non-institutional 112.67 times, and qualified institutional buyers 120.34 times.
The fresh issue of Rs 95 crore and offer-for-sale of Rs 800 crore priced at Rs 593 upper band. Anchor investors locked Rs 268.5 crore pre-open.
Grey market premium hit Rs 96, eyeing Rs 689 debut—up 16.19%. Experts attribute buzz to the firm's excipient dominance.
Allotment details live on BSE, NSE, and MUFG sites. Unallotted refunds initiate November 27; credits follow.
Sudeep Pharma, founded 1989, supplies 200+ ingredients to pharma, food sectors. FY25 revenue Rs 761 crore, losses Rs 394 crore from HQ shift.
Proceeds fund tech upgrades, R&D. Listing November 28 promises liquidity boost.
This IPO underscores specialty chemical sector's appeal, with 30% anchor allocation signaling confidence.
